Furthermore, a greater proportion of patients achieved HbA 1c reduction 1% with body weight loss 3% at Week 26 with oral semaglutide 7 and 14 mg than with placebo and active comparators [38, 39, 61, 62, 76, 77, 81, 82]
Semaglutide has been shown to improve insulin sensitivity and glycemic control, which is particularly beneficial for individuals with type 2 diabetes or prediabetes
What Results Do Patients Typically Experience
Malavika Athavale, Consulting Clinical and IBS Nutritionist Side effects of both Wegovy and Ozempic are usually similar
Doctor Dialogue Thus, open, specific talk between patient and physician about semaglutide is crucial
Doctors say many patients misunderstand the role of the drugs